There will be a shareholder meeting on Dec. 4 to approve the transaction. The company hopes to complete the transaction swiftly after approval, but is still subject to customary closing conditions. There is no assurance on the ultimate timing of the proposed transaction and Symmetry Medical does not intend to provide regular updates on the progress.
However, there will be an announcement when the transaction is complete.
More articles on orthopedic devices:
Stryker hip implant settlement to exceed $1.4B—10 key facts
Orthopedic device market stock report—5 company updates
Alphatec Spine 3Q revenue up 2%: 10 key concepts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
